Company
The company plans to develop state-of-the-art nano-technology based biosensors that have high sensitivity and specificity, and are accurate and affordable for patients globally. The product will revolutionalize the ability to detect and monitor diseases real-time via a simple process that can be conducted at any point-of-care.
